Lung Cancer Trial, Not Yet Recruiting (NCT06725225)

Lung Cancer Trial, Not Yet Recruiting NCT06725225 Sponsor: Second Affiliated Hospital of Zunyi Medical University Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06725225 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

People who have been diagnosed with lung cancer confirmed by a tissue sample or biopsy.
People who are over 18 years of age.
People who are currently receiving immunotherapy treatment for lung cancer.
People who are able to communicate clearly by speaking.
People who have given written agreement to participate, either themselves or through a family member.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

People who have a cognitive impairment or a mental illness.
People who have other serious health conditions.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8618311543939

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06725225

Sponsor: Second Affiliated Hospital of Zunyi Medical University

Phase: Not Applicable

Status: Not Yet Recruiting

Condition: Lung Cancer

Trial contact: +8618311543939

More information: https://clinicaltrials.gov/study/NCT06725225

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who may be able to join

People who have been diagnosed with lung cancer confirmed by a tissue sample or biopsy.
People who are over 18 years of age.
People who are currently receiving immunotherapy treatment for lung cancer.
People who are able to communicate clearly by speaking.
People who have given written agreement to participate, either themselves or through a family member.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

People who have a cognitive impairment or a mental illness.
People who have other serious health conditions.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Not Yet Recruiting

Phase

Not Applicable

Sponsor

Second Affiliated Hospital of Zunyi Medical University

Registry

ClinicalTrials.gov

Start date

1 January 2025

Est. completion

1 December 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Primary endpoints

EORTC QLQ C30; EORTC QLQ LC-13

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov

Who may and may not be able to join

Who may be able to join

Who may not be able to join

Contact this trial

GP referral letter

Who may be able to join

Who may not be able to join

Trial details

Primary endpoints

Can't join this trial?

Expanded access pathways

Other trials for Lung Cancer